Isophane Protamine Recombinant Human Insulin (Jilin Huisheng Biological )
精蛋白重组人胰岛素注射液（吉林惠升）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameIsophane Protamine Recombinant Human Insulin (Jilin Huisheng Biological )
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJilin Huisheng Biopharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesJilin Huisheng Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A